NCATS Preclinical Proof of Concept Studies for Rare Diseases

National Center for Advancing Translational Sciences

Open

Opportunity summary

What we know

Funds U.S. researchers and companies conducting preclinical efficacy studies to advance therapeutic candidates for rare diseases toward IND applications.

Last checked 22 Jul 2026.

Build the right funding mix

Connect grants, investors and strategic programmes around the milestones that matter.

Start your raise